Haier Group displayed exoskeleton products at the World Robot Conference in Beijing in August, signaling a decisive shift in how wearable robotic technology is being deployed in everyday life. What was once confined to hospitals and factory floors is now becoming a consumer product—and that transformation raises urgent questions about who benefits from this technology and who gets left behind.
Exoskeletons, wearable devices that augment physical activity and are also known as powered suits, are beginning to muscle their way into everyday life in China. The devices are starting to become part of daily experience, marking a significant shift for technology that has long been associated with medical and industrial uses. Appliance makers and startups are racing into what the market describes as a nascent field, competing fiercely to establish themselves as the technology moves beyond its traditional roles.
The Emerging Market
The products being shown publicly—including those displayed at the World Robot Conference in Beijing in August—represent the first wave of consumer-facing exoskeleton technology. This isn't incremental change. It's a fundamental reorientation of where and how this technology will be deployed. Haier Group's presence at the conference underscores how serious major appliance manufacturers are about entering this space. When established industrial players move into a new market, it typically signals they see real commercial potential and consumer demand.
The fact that the market is described as nascent matters. It means there's still time for policy decisions to be made about how this technology develops, who has access to it, and what safeguards protect workers and consumers. These early stages are when regulatory frameworks get built—or don't.
Questions of Access and Equity
As exoskeletons move from specialized medical and industrial contexts into the consumer mainstream, fundamental questions emerge about distribution and affordability. Medical exoskeletons have historically been expensive, accessible primarily to hospitals and wealthy patients. Industrial models have been deployed by large manufacturers with the capital to invest in them. Consumer versions could democratize access to physical augmentation technology—or they could create a new form of inequality where only affluent individuals and well-resourced employers can afford them.
The shift from medical and industrial applications to consumer products also changes who bears responsibility for safety and efficacy. Medical devices face rigorous regulatory oversight. Consumer products often face lighter regulation. Workers in factories using industrial exoskeletons operate within defined legal frameworks around workplace safety. Consumers buying these devices for personal use may have far fewer protections.
Why This Matters:
The movement of exoskeleton technology into the consumer mainstream in China represents a critical juncture for how transformative technologies are governed and distributed. As these devices become accessible to ordinary people—not just medical patients or industrial workers—societies must grapple with questions of affordability, safety standards, and equitable access. The regulatory choices made now, while the market is still forming, will determine whether exoskeletons become tools that broadly enhance human capability or devices that deepen existing inequalities. Additionally, the expansion of this technology raises labor questions: if exoskeletons become widely available to consumers and employers, how do workplace protections and wage standards adapt? The early commercialization phase is when these structural decisions get made, often with limited public input. How China's market develops—and whether other nations follow similar or different paths—will shape whether robotic augmentation becomes a shared benefit or a source of new disparities.